Related references
Note: Only part of the references are listed.Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action
Caslin A. Gilroy et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity
Eric M. Mastria et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude
Jacob S. Brenner et al.
NATURE COMMUNICATIONS (2018)
Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas
Jun Gong et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy
Lingling Shan et al.
THERANOSTICS (2018)
Hydrazone linkages in pH responsive drug delivery systems
Sandeep J. Sonawane et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes
Mauro Cataldi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Albumin Binding Domain Fusing R/K-X-X-R/K Sequence for Enhancing Tumor Delivery of Doxorubicin
Liping Liu et al.
MOLECULAR PHARMACEUTICS (2017)
Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth
Jayanta Bhattacharyya et al.
NANOSCALE (2017)
Zika Virus and the Blood Supply: What Do We Know?
Alexandra Jimenez et al.
TRANSFUSION MEDICINE REVIEWS (2017)
Discovery and technology for human health
[Anonymous]
NATURE BIOMEDICAL ENGINEERING (2017)
Encapsulating a Hydrophilic Chemotherapeutic into Rod-Like Nanoparticles of a Genetically Encoded Asymmetric Triblock Polypeptide Improves Its Efficacy
Jayanta Bhattacharyya et al.
ADVANCED FUNCTIONAL MATERIALS (2017)
Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment
Yi Liu et al.
BIOCONJUGATE CHEMISTRY (2016)
The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment
Jinqiang Wang et al.
ACS NANO (2015)
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
Jonathan T. Sockolosky et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Anthracyclines potentiate anti-tumor immunity: A new opportunity for chemoimmunotherapy
Zhigang Zhang et al.
CANCER LETTERS (2015)
A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models
Jayanta Bhattacharyya et al.
NATURE COMMUNICATIONS (2015)
The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration
Yong-Bo Hu et al.
TRANSLATIONAL NEURODEGENERATION (2015)
Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants
R. D. Christensen et al.
JOURNAL OF PERINATOLOGY (2015)
Co-opting Biology to Deliver Drugs
Parisa Yousefpour et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior
Huile Gao et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
A clinical update of using albumin as a drug vehicle - A commentary
Felix Kratz
JOURNAL OF CONTROLLED RELEASE (2014)
The effect of the neonatal Fc receptor on human IgG biodistribution in mice
Nancy Chen et al.
MABS (2014)
Unraveling the mysteries of serum albumin-more than just a serum protein
Angelica M. Merlot et al.
FRONTIERS IN PHYSIOLOGY (2014)
An Evaluation of Hepatotoxicity in Breast Cancer Patients Receiving Injection Doxorubicin
G. Damodar et al.
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2014)
Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells
Aaron C. Anselmo et al.
ACS NANO (2013)
Human serum albumin from recombinant DNA technology: Challenges and strategies
Zhen Chen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Acidity Generated by the Tumor Microenvironment Drives Local Invasion
Veronica Estrella et al.
CANCER RESEARCH (2013)
The thiol pool in human plasma: The central contribution of albumin to redox processes
Lucia Turell et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein
Anna Orlova et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
THE ALBUMIN-BINDING DOMAIN AS A SCAFFOLD FOR PROTEIN ENGINEERING
Johan Nilvebrant et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2013)
Tumor delivery of macromolecular drugs based on the EPR effect
Vladimir Torchilin
ADVANCED DRUG DELIVERY REVIEWS (2011)
Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
Stephen R. Mattarollo et al.
CANCER RESEARCH (2011)
Endosome maturation
Jatta Huotari et al.
EMBO JOURNAL (2011)
Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain
Jan Terje Andersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Adriamycin Nephropathy A Failure of Endothelial Progenitor Cell-Induced Repair
Kaoru Yasuda et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Recursive Directional Ligation by Plasmid Reconstruction Allows Rapid and Seamless Cloning of Oligomeric Genes
Jonathan R. McDaniel et al.
BIOMACROMOLECULES (2010)
Doxorubicin Cardiomyopathy
Kanu Chatterjee et al.
CARDIOLOGY (2010)
Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
J. Lofblom et al.
FEBS LETTERS (2010)
INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model
R. Graeser et al.
INVESTIGATIONAL NEW DRUGS (2010)
Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Yi-Wei Zhang et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
M. Marre et al.
DIABETIC MEDICINE (2009)
Nanoparticle-based targeted drug delivery
Rajesh Singh et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection
J. Andrew MacKay et al.
NATURE MATERIALS (2009)
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Felix Kratz
JOURNAL OF CONTROLLED RELEASE (2008)
Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism
Shreeram Akilesh et al.
JOURNAL OF IMMUNOLOGY (2007)
DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials
Felix Kratz
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
pH-dependent protein conformational changes in albumin:gold nanoparticle bioconjugates:: A spectroscopic study
Li Shang et al.
LANGMUIR (2007)
Emerging infectious diseases that threaten the blood supply
Harvey J. Alter et al.
SEMINARS IN HEMATOLOGY (2007)
G148-GA3: A streptococcal virulence module with atypical thermodynamics of folding optimally binds human serum albumin at physiological temperatures
DA Rozak et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Experience with eosin-5′-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders
PS Kedar et al.
CLINICAL AND LABORATORY HAEMATOLOGY (2003)
Lymphocyte surface thiol levels
B Sahaf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan
C Chaudhury et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Identification of B- and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148
L Goetsch et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2003)
Structure, specificity, and mode of interaction for bacterial albumin-binding modules
MU Johansson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
